Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

Leone, A., Moncada, S., Vallance, P., Calver, A., & Collier, J. (1992) · The Lancet · doi:10.1016/0140-6736(92)90865-z · Cited by 2,107 · see citing works

Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial Dysfunction: Its Role in Hypercholesterolemia

Böger, R. H., Bode-Böger, S. M., Szuba, A., Tsao, P. S., Chan, J. R., Tangphao, O., Blaschke, T. F., & Cooke, J. P. (1998) · Circulation · doi:10.1161/01.cir.98.18.1842 · Cited by 1,181 · see citing works

Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine

Drexler, H., Zeiher, A. M., Meinzer, K., & Just, H. (1991) · The Lancet · doi:10.1016/0140-6736(91)92372-9 · Cited by 801 · see citing works

Endogenous Nitric Oxide Synthase Inhibitor

Miyazaki, H., Matsuoka, H., Cooke, J. P., Usui, M., Ueda, S., Okuda, S., & Imaizumi, T. (1999) · Circulation · doi:10.1161/01.cir.99.9.1141 · Cited by 756 · see citing works

Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit.

Cooke, J. P., Singer, A. H., Tsao, P. S., Zera, P. H., Rowan, R. A., & Billingham, M. E. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115937 · Cited by 687 · see citing works

Novel Mechanism for Endothelial Dysfunction

Ito, A., Tsao, P. S., Adimoolam, S., Kimoto, M., Ogawa, T., & Cooke, J. P. (1999) · Circulation · doi:10.1161/01.cir.99.24.3092 · Cited by 629 · see citing works

Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits.

Cayatte, A. J., Palacino, J. J., Horten, K., & Cohen, R. A. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.5.753 · Cited by 491 · see citing works

Biochemical Evidence for Impaired Nitric Oxide Synthesis in Patients With Peripheral Arterial Occlusive Disease

Böger, R. H., Bode‐Böger, S. M., Thiele, W., Junker, W., Alexander, K., & Frölich, J. C. (1997) · Circulation · doi:10.1161/01.cir.95.8.2068 · Cited by 490 · see citing works

LDL Cholesterol Upregulates Synthesis of Asymmetrical Dimethylarginine in Human Endothelial Cells

Böger, R. H., Sydow, K., Borlak, J. T., Thum, T., Lenzen, H., Schubert, B., Tsikas, D., & Bode‐Böger, S. M. (2000) · Circulation Research · doi:10.1161/01.res.87.2.99 · Cited by 478 · see citing works

Long-term l -Arginine Supplementation Improves Small-Vessel Coronary Endothelial Function in Humans

Lerman, A., Burnett, J. C. J., Higano, S. T., McKinley, L. J., & Holmes, D. R. (1998) · Circulation · doi:10.1161/01.cir.97.21.2123 · Cited by 426 · see citing works

Reduced Urinary Excretion of Nitric Oxide Metabolites and Increased Plasma Levels of Asymmetric Dimethylarginine in Men with Essential Hypertension

Surdacki, A., Nowicki, M. P., Sandmann, J., Tsikas, D., Boeger, R. H., Bode-Boeger, S. M., Kruszelnicka-Kwiatkowska, O., Kokot, F., Dubiel, J. S., & Froelich, J. C. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199904000-00020 · Cited by 422 · see citing works

Prospective Study of Hyperhomocysteinemia as an Adverse Cardiovascular Risk Factor in End-Stage Renal Disease

Moustapha, A., Naso, A., Nahlawi, M., et al. (1998) · Circulation · doi:10.1161/01.cir.97.2.138 · Cited by 407 · see citing works

Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase

MacAllister, R. J., Parry, H., Kimoto, M., Ogawa, T., Russell, R. J., Hodson, H. F., Whitley, G. S. J., & Vallance, P. J. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb16069.x · Cited by 394 · see citing works

Purification and properties of a new enzyme, N, N-dimethylarginine dimethylaminohydrolase, from rat kidney

Ogawa, T., Kimoto, M., & Sasaoka, K. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81786-0 · Cited by 364 · see citing works

Asymmetric Dimethylarginine Plasma Concentrations Differ in Patients with End-Stage Renal Disease

Kielstein, J. T., Böger, R. H., BODE-BÖGER, S. M., SCHÄFFER, J., BARBEY, M., Koch, K. M., & Frölich, J. C. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v103594 · Cited by 360 · see citing works

The Clinical Pharmacology of L-Arginine

Böger, R. H., & Bode‐Böger, S. M. (2001) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.79 · Cited by 331 · see citing works

Plasma Concentration of Asymmetric Dimethylarginine, an Endogenous Inhibitor of Nitric Oxide Synthase, Is Elevated in Monkeys With Hyperhomocyst(e)inemia or Hypercholesterolemia

Böger, R. H., Bode‐Böger, S. M., Sydow, K., Heistad, D. D., & Lentz, S. R. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.6.1557 · Cited by 278 · see citing works

Restoring vascular nitric oxide formation by l-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease

Böger, R. H., Bode‐Böger, S. M., Thiele, W., Creutzig, A., Alexander, K., & Frölich, J. C. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00375-1 · Cited by 263 · see citing works

Dietary l -Arginine Reduces the Progression of Atherosclerosis in Cholesterol-Fed Rabbits

Böger, R. H., Bode‐Böger, S. M., Brandes, R. P., Phivthong‐ngam, L., Böhme, M., Nafe, R., Mügge, A., & Frölich, J. C. (1997) · Circulation · doi:10.1161/01.cir.96.4.1282 · Cited by 242 · see citing works

Physiology and biochemistry of endothelial function in children with chronic renal failure

Kari, J. A., Donald, A. E., Vallance, D. T., Bruckdorfer, K. R., Leone, A., Mullen, M. J., Bunce, T., Dorado, B., Deanfield, J. E., & Rees, L. (1997) · Kidney International · doi:10.1038/ki.1997.354 · Cited by 220 · see citing works

Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure

MacAllister, R. J., Rambausek, M., Vallance, P. J., et al. (1996) · Nephrology Dialysis Transplantation · doi:10.1093/oxfordjournals.ndt.a027213 · Cited by 204 · see citing works

Controlling the epidemic of cardiovascular disease in chronic renal disease: Where do we start?

Levey, A. S. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v32.pm9820463 · Cited by 172 · see citing works

Serum levels of NG, NG-dimethyl-L-arginine, a potential endogenous nitric oxide inhibitor in dialysis patients.

Anderstam, B., Katzarski, K. S., & Bergström, J. P. (1997) · Journal of the American Society of Nephrology · doi:10.1681/asn.v891437 · Cited by 168 · see citing works

Response of cerebral blood vessels to an endogenous inhibitor of nitric oxide synthase

Faraci, F. M., Brian, J. E., & Heistad, D. D. (1995) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1995.269.5.h1522 · Cited by 159 · see citing works

Cardiovascular risk in uraemic patients—is it fully explained by classical risk factors?

Zoccali, C. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.4.454 · Cited by 146 · see citing works

Hemodialysis and L-arginine, but not D-arginine, correct renal failure-associated endothelial dysfunction

Hand, M. F., Haynes, W. G., & Webb, D. J. (1998) · Kidney International · doi:10.1111/j.1523-1755.1998.00851.x · Cited by 117 · see citing works

Increase of an endogenous inhibitor of nitric oxide synthesis in serum of high cholesterol fed rabbits

Yu, X., Li, Y., & Xiong, Y. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00443-9 · Cited by 115 · see citing works

Prediction of left ventricular geometry by clinic, pre-dialysis and 24-h ambulatory BP monitoring in hemodialysis patients

Zoccali, C., Mallamaci, F., Tripepi, G. L., Benedetto, F. A., Cottini, E., Giacone, G., & Malatino, L. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917120-00013 · Cited by 94 · see citing works

Chronic Kidney Disease: Effects on the Cardiovascular System

Schiffrin, E. L., Lipman, M. L., & Mann, J. F. E. (2007) · Circulation · doi:10.1161/circulationaha.106.678342 · Cited by 1,448 · see citing works

Cardiovascular Biology of the Asymmetric Dimethylarginine:Dimethylarginine Dimethylaminohydrolase Pathway

Vallance, P., & Leiper, J. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000128897.54893.26 · Cited by 553 · see citing works

Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation

Tejero, J., Shiva, S., & Gladwin, M. T. (2019) · Physiological Reviews · doi:10.1152/physrev.00036.2017 · Cited by 541 · see citing works

The role of oxidative stress in the pathophysiology of hypertension

Rodrigo, R., González, J., & Paoletto, F. (2011) · Hypertension Research · doi:10.1038/hr.2010.264 · Cited by 436 · see citing works

Asymmetrical Dimethylarginine: The Über Marker?

Cooke, J. P. (2004) · Circulation · doi:10.1161/01.cir.0000126823.07732.d5 · Cited by 396 · see citing works

Asymmetric Dimethylarginine, an Endogenous Inhibitor of Nitric Oxide Synthase, Explains the “L-Arginine Paradox” and Acts as a Novel Cardiovascular Risk Factor

Böger, R. H. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.10.2842s · Cited by 363 · see citing works

Symmetric dimethylarginine (SDMA) as endogenous marker of renal function–a meta-analysis

Kielstein, J. T., Salpeter, S. R., Bode-Boeger, S. M., Cooke, J. P., & Fliser, D. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl292 · Cited by 363 · see citing works

Plasma Asymmetric Dimethylarginine and Incidence of Cardiovascular Disease and Death in the Community

Böger, R. H., Sullivan, L. M., Schwedhelm, E., Wang, T. J., Maas, R., Benjamin, E. J., Schulze, F., Xanthakis, V., Benndorf, R. A., & Vasan, R. S. (2009) · Circulation · doi:10.1161/circulationaha.108.838268 · Cited by 351 · see citing works

The l-arginine paradox: Importance of the l-arginine/asymmetrical dimethylarginine ratio

BODEBOGER, S., SCALERA, F., & IGNARRO, L. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.03.002 · Cited by 347 · see citing works

Abnormal High-Density Lipoprotein Induces Endothelial Dysfunction via Activation of Toll-like Receptor-2

Speer, T., Rohrer, L., Blyszczuk, P., Shroff, R., Kuschnerus, K., Kränkel, N., Kania, G., Zewinger, S., Akhmedov, A., Shi, Y., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.009 · Cited by 310 · see citing works

Oxidative stress in chronic kidney disease

Ling, X. C., & Kuo, K.-L. (2018) · Renal Replacement Therapy · doi:10.1186/s41100-018-0195-2 · Cited by 183 · see citing works

Sympathetic Overactivity in Chronic Kidney Disease: Consequences and Mechanisms

Kaur, J., Young, B., & Fadel, P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081682 · Cited by 168 · see citing works

Flow, NO, and atherogenesis

Cooke, J. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0430082100 · Cited by 135 · see citing works

PROGRESS IN UREMIC TOXIN RESEARCH: Guanidino Compounds as Uremic (Neuro)Toxins

De Deyn, P. P., Vanholder, R., Eloot, S., & Glorieux, G. (2009) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2009.00577.x · Cited by 131 · see citing works

Serum Metabolite Concentrations and Decreased GFR in the General Population

Goek, O.-N., Döring, A., Gieger, C., Heier, M., Koenig, W., Prehn, C., Römisch-Margl, W., Wang-Sattler, R., Illig, T., Suhre, K., et al. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.01.014 · Cited by 121 · see citing works

Asymmetric dimethylarginine (ADMA): a potential link between endothelial dysfunction and cardiovascular diseases in insulin resistance syndrome?

N., C., & J., C. (2002) · Diabetologia · doi:10.1007/s00125-002-0975-6 · Cited by 116 · see citing works

Asymmetric dimethylarginine (ADMA) is a novel emerging risk factor for cardiovascular disease and the development of renal injury in chronic kidney disease

Ueda, S., Yamagishi, S.-I., Matsumoto, Y., Fukami, K., & Okuda, S. (2007) · Clinical and Experimental Nephrology · doi:10.1007/s10157-007-0471-x · Cited by 65 · see citing works

The effect of dietary nitrate supplementation on the oxygen cost of cycling, walking performance and resting blood pressure in individuals with chronic obstructive pulmonary disease: A double blind placebo controlled, randomised control trial

Shepherd, A. I., Wilkerson, D. P., Dobson, L., Kelly, J., Winyard, P. G., Jones, A. M., Benjamin, N., Shore, A. C., & Gilchrist, M. (2015) · Nitric Oxide · doi:10.1016/j.niox.2015.01.002 · Cited by 88 · see citing works

Under- and Normal-Weight Patients Are More Susceptible to Recurrence of Phyllodes Tumor

Kim, Y. Y., Kim, H., Kim, W. Y., et al. (2022) · The Breast Journal · doi:10.1155/2022/4474251 · Cited by 2 · see citing works

Multivariate analysis of prognostic factors in pediatric and adult thalamic and brainstem tumors

Grigsby, P. W., Thomas, P. R., Schwartz, H. G., et al. (1989) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(89)90480-x · Cited by 35 · see citing works

AN ANALYSIS OF HEPATIC RETRANSPLANTATION IN CHILDREN

Newell, K. A., Millis, J. M., Bruce, D. S., et al. (1998) · Transplantation · doi:10.1097/00007890-199805150-00005 · Cited by 47 · see citing works

The influence of age on postoperative complications after total laryngectomy or pharyngolaryngectomy

Lagier, A., Mimouni-Benabu, O., Baumstarck, K., et al. (2013) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2013.09.010 · Cited by 20 · see citing works

Univariate and multivariate statistical analysis of high-grade gliomas: The relationship of radiation dose and other prognostic factors

Miller, P. J., HASSANEIN, R. S., Giri, P. G. S., Kimler, B. F., OʼBoynick, P. L., & Evans, R. G. B. (1990) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(90)90534-q · Cited by 71 · see citing works